BioLine RX Ltd (BLRX.OQ)
BLRX.OQ on NASDAQ Stock Exchange Capital Market
Change (% chg)
Revenue & Earnings Per Share
Consensus Estimates Analysis
No consensus analysis data available.
Performance for BioLine RX Ltd
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-BioLineRx Announces Notice of Allowance From USPTO for Patent Covering Immunotherapy for Treating Solid Tumors
- BRIEF-Biolinerx Reports Year End 2017 Financial Results
- BRIEF-Biolinerx Announces Partial Monotherapy Results From Phase 2A Combat Study In Pancreatic Cancer
- BRIEF-Bioline Rx Ltd Files For Mixed Shelf Of Up To $150 Million
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.